Final program (PDF 475kB)

This is the author’s version of a work that was submitted/accepted for publication in the following source:
O’Connor, Martin, Lim, David, Ward, Lauren, & Hepworth, Julie
(2014)
Integrated chronic disease management in primary-secondary care : a
systematic literature review of the evidence. In
Andrikopoulous, Sof, Aylen, Tracey, Gunton, Jenny, & Joannides, Christos
(Eds.)
Australian Diabetes Society and Australian Diabetes Educators Association Annual Scientific Meeting 2014, 27 - 29 August 2014, Melbourne,
Australia. (Unpublished)
This file was downloaded from: http://eprints.qut.edu.au/75961/
c Copyright 2014 Please consult the authors
Notice: Changes introduced as a result of publishing processes such as
copy-editing and formatting may not be reflected in this document. For a
definitive version of this work, please refer to the published source:
SCIENTIFIC PROGRAM – Wednesday 27th August, 2014
Breakfast Sessions - Concurrent
Abbott Nutrition Breakfast Symposium
7:00am - 8:15am
The HBA1c Balancing act” – Medical Nutrition Therapy and Lifestyle Intervention
Meeting Room 209
Medtronic Diabetes Breakfast Symposium
7:00am - 8:15am
Beyond Low Glucose Suspend: Progressing towards closing the loop
Meeting Room 212
AstraZeneca Breakfast Symposium
7:00am - 8:15am
Continuous Glucose Re absorption & the Cycle of Glucose Toxicity
Meeting Room 213
Takeda Australia Breakfast Symposium
7:00am - 8:15am
Meeting Room 218
Getting to the heart of the matter - Developments in the diagnosis and treatment paradigms for type 2 diabetes
Breakfast Meetings
ESA-SRB-ADS-ADEA President's Breakfast
7:00am - 8:30am
Hospitality Suite 5.201 & 5.202
ADEA Meeting: Award Judges
7:00am - 8:30am
Meeting Room 216
Concurrent Sessions
Joint ADS & ADEA Welcome
8:30am - 8:45am
Plenary Hall 2
Carolyn Briggs, Senior Elder of the Boon Wurrung Foundation
Welcome to Country
Georgie Crozier MLC; Parliamentary Secretary of Health
Conference Opening
Jenny Gunton and Tracy Aylen
Welcome from ADS & ADEA Presidents
ADS Clinical Symposium: Pipeline Blood Glucose-Lowering Therapies
8:30am - 10:30am
*Recorded Session*
*GP CME Eligible Session*
Meeting Room 211
This conference acknowledges the sponsorship of MSD Australia
Chair: Greg Fulcher & Sof Andrikopoulos
8:30 AM
Ele Ferrannini
Pipeline blood glucose-lowering therapies abs# 1
9:00 AM
Timothy Davis
Novel therapies for type 2 diabetes abs# 2
9:30 AM
John Prins
DPP-4i/GLP-Ra abs# 3
10:00 AM
Stephen Colagiuri
Title not available at time of print abs# 4
ADS Clinical Orals: Diagnosis, Glycaemia and Outcomes
8:30am - 10:30am
Meeting Room 217
Chair: Jonathan Shaw & Spiros Fourlanos
8:30 AM
Natalie Nanayakkara
Hospital-wide HbA1c measurement identifies undiagnosed diabetes in 5% of patients aged 54 years
and over: results of the Austin Health Diabetes Discovery Initiative abs# 5
8:45 AM
Natalie Nanayakkara
Routine HbA1c measurement identifies undiagnosed diabetes in 20% of general medical inpatients
with an HbA1c ≥ 6.5%: results of the Austin Health Diabetes Discovery Initiative abs# 6
9:00 AM
Jasmine Lyons
Higher estimated glomerular filtration is associated with insulin resistance in healthy, non-diabetic
humans, independent of adiposity abs# 7
9:15 AM
Spiros Fourlanos
Adverse glycaemic events and lack of treatment escalation: time for hospital action abs# 8
9:30 AM
Paul Drury
Diabetes across the Ditch: Winning Battles but Losing the War? abs# 9
9:45 AM
Peter Colman
Greater length of hospital stay in diabetes inpatients: 2002-2013 abs# 10
10:00 AM
Neale Cohen
Trends in blood glucose levels and management of diabetes in 467,955 patients in primary care in
Australia from 2005 to 2013 abs# 11
10:15 AM
N Wah Cheung
Glucose Management in a Cluster Randomized Trial of Evidence-Based Treatment Protocols for
Acute Stroke (QASC) abs# 12
ADS Basic Orals: Liver & Insulin Resistance
8:30am - 10:30am
Meeting Room 218
Chair: Lindsay Wu & Graeme Lancaster
8:30 AM
Greg Kowalski
Understanding the physiological and biochemical causes of high-fat diet induced defects in hepatic
glucose metabolism abs# 13
8:45 AM
Carsten Schmitz-Peiffer
Protein kinase C epsilon deletion in adipose tissue, but not in liver, modulates fatty acid mobilisation
and hepatic insulin action abs# 14
9:00 AM
Amanda Genders
Protein kinase D regulates hepatic glucose metabolism in vitro and in vivo abs# 15
9:15 AM
Magdalene Montgomery
Unique changes in hepatic sphingolipid species after high-fat feeding in BALB/c mice correlate with
protection from diet-induced glucose intolerance abs# 16
9:30 AM
Xiu Zhou
Hepatic FoxO1 acetylation is involved in oleanolic acid-induced memory of glycemic control abs# 17
9:45 AM
Mark Gorrell
DPP4 and FAP in glucose and lipid metabolism and liver injury in mice abs# 18
10:00 AM
Sahar Keshvari
Characterisation of the Adiponectin Receptors: Palmitoylation of AdipoR1 and AdipoR2 is Required
for Efficient Cell-Surface Expression and Down-Stream Signalling abs# 19
10:15 AM
Tamara Allen
Acute administration the IL-6-CNTF chimera IC7 improves glucose tolerance via suppression of
hepatic gluconeogenesis abs# 20
Plenary Lectures
ADS & ESA Plenary Lecture
8:45am - 9:30am
*Recorded Session*
Chair: Morton Burt
8:45 AM
Adrian Clark
Dissecting the genetic basis of inherited adrenocortical failure
Plenary Hall 2
abs# 21
ADEA Plenary Lecture
9:30am - 10:15am
*Recorded Session*
Plenary Hall 2
This conference acknowledges the sponsorship of Novo Nordisk
Chairs: Tracy Aylen & Trish Roderick
9:30 AM
Teresa Pearson
Transforming Diabetes Care: A Sacred Trust
abs# 22
Concurrent Sessions
ADS & ESA Joint Symposium
9:30am - 10:30am
Meeting Room 203-204
Chair: Peter Fuller & Leon Bach
9:30 AM
Morag Young
Mineralocorticoid receptors: cardiac fibrosis, metabolism and inflammation abs# 23
9:50 AM
Patrick Sexton
New insights into signaling at the glucagon-like peptide-1 receptor abs# 24
10:10 AM
Adrian Clark
The melanocortin 2 receptor accessory proteins abs# 25
Morning Tea
10:30am - 11:00am
Trade Exhibition Hall
This conference acknowledges the sponsorship of Servier Laboratories
Concurrent Sessions
ADEA Symposium: Diabetes Distress and Depression - Facing Challenges, Bringing Solutions
(abs#26)
11:00am - 1:00pm
*Recorded Session*
Plenary Hall 2
This conference acknowledges the sponsorship of Roche Diagnostics
Chairs: Anne Morris & Jane Speight
Presented by:
Jane Speight
Christel Hendrieckx
Ann Morris
Linda Beeney
Jennifer Halliday
Lauren Tyrrell
ADS & ADEA Joint Symposium: Technology in Diabetes
11:00am - 1:00pm
Meeting Room 203-204
*GP CME Eligible Session*
Chair: Brett Fenton
11:00 AM
Kathleen Gray
tbc abs# 27
11:30 AM
Anthony Russell
Use of Telemedicine in the Management of Diabetes abs# 28
12:00 PM
Annie Lau
How E-Health Affects the Way Patients and Consumers Make Decisions and Manage Their Health
abs# 29
12:30 PM
Veronica Mills
Smartphone technology satisfaction and usefulness study for improved self management in type 1
adults
abs# 30
12:45 PM
Victoria Stevenson
A Diabetes Technology Nurse Makes a Difference at Austin Health abs# 31
NADC Symposium
11:00am - 1:00pm
Meeting Room 211
*Recorded Session*
Chair: Wah Cheung
11:00 AM
Peter Colman
Implementing and utilizing the Biogrid Database in Diabetes Centres abs# 32
11:25 AM
Giuliana Murfet
Management of Diabetes in the General Care Setting Update abs# 33
11:50 AM
Sophia Zoungas & Bethany Crinall
Australian National Diabetes Audit- Australian Quality Clinical Audit 2013 abs# 34
12:15 PM
Elaine Pretorius
NADC accreditation abs# 35
12:40 PM
Natalie Wischer
NADC Q&A session abs# 36
ADEA Symposium: The CDE - The 007 of Diabetes Education
11:00am - 1:00pm
Chairs: Rachel McKeown
11:00 AM
Lorraine Pitman
Relationship and Engagement, a Perfect Partnership with your CDE
11:30 AM
Dianna Fornasier
Centralised Team Model Embedded In General Practice abs# 38
12:00 PM
Teresa Pearson
The USA Experience abs# 39
12:30 PM
Rachel McKeown & Vy Le
New Gadgets for CDEs abs# 40
Meeting Room 213
abs# 37
ADS Basic Symposium: Complications
11:00am - 1:00pm
Meeting Room 218
Chair: Josephine Forbes
11:00 AM
Kumar Sharma
Mitochondria Hormesis and Diabetic Nephropathy: A New Paradigm abs# 41
11:30 AM
Roger Shi
Pathological Cardiolipin Remodeling by ALCAT1 Controls Mitochondrial Etiology of Diabetic
Complications abs# 42
12:00 PM
David Thorburn
Monogenic causes of mitochondrial disease and their impact on metabolism abs# 43
12:30 PM
Melinda Coughlan
Disturbed mitochondrial homeostasis and diabetic nephropathy: are we any closer to a targeted
therapy?
abs# 44
ADS Clinical Orals - Brain Structure, Function and Mental Health in Diabetes
11:00am - 1:00pm
Meeting Room 209
Chair: Helena Teede
11:00 AM
Katherine Samaras
Detangling insulin and glucose and the mind: brain structure, function and incident dementia in the
Sydney Memory and Ageing Study abs# 45
11:15 AM
Katherine Samaras
The effects of statin use and metabolic syndrome on cognitive decline in the elderly: the Sydney
Memory and Ageing Study abs# 46
11:30 AM
Katherine Samaras
Preventing double jeopardy: diabetes and obesity risk minimization in youth with severe mental
illness receiving antipsychotic medications. The Keeping the Body in Mind Program abs# 47
11:45 AM
Giesje Nefs
Depression symptom clusters differentially predict cardiovascular hospitalisation in people with type
2 diabetes abs# 48
12:00 PM
Kylie Mosely
Associations between depression, motivation, and physical activity in adults with type 2 diabetes:
Results from the Diabetes PACT Study abs# 49
12:15 PM
Margaret McGill
Evidence of greater impact of diabetes complications on the mental health of Asian immigrants: a
hidden co-morbidity abs# 50
12:30 PM
Tonelle Handley
Suicidal Ideation and Self-Harm in Type 1 and Type 2 Diabetes: Results from Diabetes MILES Australia abs# 51
12:45 PM
Wendy Davis
Schizophrenia is an independent risk factor for all-cause mortality in type 2 diabetes: The Fremantle
Diabetes Study abs# 52
Lunch
1:00pm - 2:00pm
Trade Exhibition Hall
This conference acknowledges the sponsorship of Sanofi Diabetes
Lunchtime Meetings:
ADEA Meeting: Past Presidents
1:00pm - 2:00pm
ESA-SRB-ADS-ADEA 2015 Program Planning Meeting
1:00pm - 2:00pm
Hospitality Suite 5.204
Meeting Room 209
ADEA e-Posters
1:00pm - 3:30pm
Trade Exhibition Hall
Terminals for viewing the e-posters are provided in the exhibition hall. A complete listing of e-posters can be found
later in the program and on the smart phone/mobile device ‘app’.
ADS Basic Poster Viewing
2:00pm - 3:00pm
Please see the poster listing for all presenters.
Trade Exhibition Hall
ADS Basic Poster Discussions
2:00pm - 3:00pm
Please see poster listing for poster presenters giving short discussions.
Trade Exhibition Hall
ADEA Poster Viewing One
2:00pm - 3:00pm
Please see the poster listing for all presenters.
Trade Exhibition Hall
Plenary Lecture
ADS Plenary Lecture
2:00pm - 2:30pm
*Recorded Session*
Plenary Hall 2
This conference acknowledges the sponsorship of MSD Australia
Chair: Timothy Davis
2:00 PM
Rury Holman
Title not available at time of print
abs# 53
ADEA Meeting: Editorial Advisory Group
2:00pm - 3:00pm
Hospitality Suite 5.204
Concurrent Sessions
Bioscientifica Symposium: Practical Publishing Advice
2:00pm - 3:30pm
Chair: Sof Andrikopoulos
2:00 PM
Sof Andrikopoulos
Introduction
2:05 PM
Peter Ebeling
The art of scientific writing
2:20 PM
Dagmar Wilhelm
The peer review process
2:35 PM
Jerry Greenfield
Responding to reviewer comments
2:50 PM
Adrian Clark
Publishing ethics: Fabrication, Falsification and Plagiarism
3:05 PM
Questions and discussion
Meeting Room 212
Plenary Lecture
ADS Plenary Lecture
2:30pm - 3:00pm
*Recorded Session*
Plenary Hall 2
This conference acknowledges the sponsorship of AstraZeneca
Chair: Joseph Proietto
2:30 PM
Ele Ferrannini
Cross-talk between insulin resistance and ß-cell dysfunction in type 2 diabetes : clinical implications
abs# 54
Afternoon Tea
3:00pm - 3:30pm
ADEA Meeting: Branch Chairs
3:30pm - 5:00pm
Trade Exhibition Hall
This conference acknowledges the sponsorship of Abbott Nutrition
Hospitality Suite 5.201 & 5.202
Concurrent Sessions
ADS & ADEA Joint Debate: "Carbs - Victim or Villain for Diabetes"
3:30pm - 5:30pm
*Recorded Session*
*GP CME Eligible Session*
Chairs: Sof Andrikopoulos & Natalie Wischer
Villain - Timothy Noakes, Troy Stapleton & Ron Raab
Victim - Gary Kilov, Nicole Kellow & Bill Shrapnel
Plenary Hall 2
ADS Clinical Young Investigator Awards
3:30pm - 5:30pm
Meeting Room 203-204
Chairs: Jenny Gunton & Stephen Twigg
3:30 PM
Sharon Yeoh
Impact of Specialised Inpatient Diabetes Service on Hospital Stay and Complications abs# 55
3:45 PM
Kathryn Williams
Utility of Lower Serum Fibroblast Activation Protein in the Exclusion of Clinically Significant Liver
Fibrosis Due to Non-alcoholic Fatty Liver Disease in Diabetes and Obesity abs# 56
4:00 PM
Kharis Burns
Access to a Transition Diabetes Service for Young Adults with Type 1 Diabetes (T1DM) Reduces
Frequency and Length of Stay of Diabetic Ketoacidosis (DKA) Admissions abs# 57
4:15 PM
Chelsea McMahon
Incident glucose disorders and all-cause mortality at 15 years in treated HIV-infection abs# 58
4:30 PM
2012 ADS-Sanofi Diabetes Research Grant Awardee
Sybil McAuley
The Impact of Exercise on the Fall in Plasma Insulin Following Reduction of Basal Insulin Pump
Infusion Rates in People with Type 1 Diabetes abs# 59
4:45 PM
Renata Libianto
Relationship between NT-proBNP with 24-hour haemodynamic parameters in patients with diabetes
abs# 60
5:00 PM
Jessica Harding
Mortality trends among type 1 and type 2 diabetes in Australia 2000-2010 abs# 61
5:15 PM
Arianne Sweeting
Gestational Diabetes Mellitus in the first trimester: Evidence for poor neonatal outcomes despite
treatment abs# 62
ADEA Symposium: Clinical Symposium Managing Diabetes - “there is more to it than just sugar”
3:30pm - 5:30pm
*Recorded Session*
Meeting Room 211
This conference acknowledges the sponsorship of Janssen
Chairs: Kathy Grudzinskas & Catherine Anderson
3:30 PM
George Barker
An update on changes to the HbA1c abs# 63
4:00 PM
Nic Kormas
Management of Diabetes; HbA1c or BMI? That is the question abs# 64
4:30 PM
Anna Crawford
BIG FOOT. Assessing the feet and footwear of obese patients with diabetes when recommending an
increase in weight-bearing activity abs# 65
5:00 PM
Dianne Bennett
Title not available at time of print abs# 66
ADS Basic Symposium: Networking Diabetes
3:30pm - 5:30pm
Meeting Room 219
Chair: Mark Febbraio
3:30 PM
Alan Attie
Sorcs1: from diabetes QTL to cellular function abs# 67
4:00 PM
Grant Morahan
Defining Networks of Interacting Genetic Variants that Contribute to Type 1 Diabetes, Type 2
Diabetes and Diabetes Complications abs# 68
4:30 PM
David James
The use of Systems Biology to study Metabolic Disease abs# 69
5:00 PM
Stephen Simpson
Macronutrient balance and the geometry of metabolism abs# 70
ADEA Orals: Innovations in Supporting the Individual with T1DM
3:30pm - 5:30pm
Meeting Room 213
Chairs: Pamela Jones & Coralie Cross
3:30 PM
Deb Foskett
Continuous Subcutaneous Insulin Infusion (CSII) in Children and Young People with Type 1 Diabetes
(TID) commenced at Diagnosis Compared to those who Commenced CSII one year or more after
Diagnosis abs# 71
3:45 PM
Alison Lancaster
Keeping adolescents with diabetes engaged with specialist diabetes services abs# 72
4:00 PM
Kathy Howe
Normalization of blood glucose levels following Islet cell transplantation (ITx) for unstable type 1
diabetes mellitus (T1DM) abs# 73
4:15 PM
Renza Scibilia
Helping young people through transition. Results from the NDSS Youth Transition Pack (YTP)
Evaluation abs# 74
4:30 PM
Jesuina Noronha & Emma White
Reproductive health knowledge, attitudes and beliefs in young women with Type 1 Diabetes Mellitus
(T1DM) aged 15 – 25 years attending a tertiary centre multidisciplinary transition clinic. Indications
for diabetes education abs# 75
4:45 PM
Elizabeth Holmes-Truscott
Structured type 1 diabetes education delivered in routine care reduces diabetes-related
emergencies and emotional distress: results from OzDAFNE abs# 76
5:00 PM
Karen Crawford
Diabetes at School – Working Towards Consistency abs# 77
5:15 PM
Lea Sorensen
A New Paediatric Model of Care Takes Diabetes Out of Hospital to the Home and Community
abs# 78
ADS Basic Orals: Complications
3:30pm - 5:30pm
Meeting Room 217
Chairs: Brooke Harcourt & Karly Sourris
3:30 PM
2012 ADS Skip Martin Early Career Fellowship Awardee
Anna Watson
Differential Intrarenal Innervation in Hypertensive and Diabetic Rodents abs# 79
3:45 PM
Bryna Chow
The Effect of C21 on Diabetics Nephropathy Progression via AT2R Activation abs# 80
4:00 PM
Anna Calkin
Transgenic expression of dominant-active IDOL in liver: A novel mouse model of
hypercholesterolaemia and atherosclerosis abs# 81
4:15 PM
Andrew Murphy
Diabetes Increases Reticulated Platelets due to Enhanced Proliferation and Expansion of Bone
Marrow Megakaryocyte Progenitors abs# 82
4:30 PM
4:45 PM
5:00 PM
5:15 PM
Juliane Czeczor
Administration of Monomeric Amyloid β42 Alters Energy Metabolism and Induces Cardiac
Dysfunction in Mice abs# 83
Jing Ren
Sitagliptin is more effective than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Gene
Expression Changes in a Rodent model of Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD)
abs# 84
Stephen Gray
The Role of Nox4 in the Diabetes Associated Atherosclerosis Development abs# 85
Robert Gilbert
New diabetes drug targets from structural characterization of liver glycogen abs# 86
Welcome Function
5:30pm - 7:00pm
Trade Exhibition Hall
This conference acknowledges the sponsorship of Novartis Pharmaceuticals
SCIENTIFIC PROGRAM – Thursday 28th August, 2014
Breakfast Sessions - Concurrent
Eli Lilly Breakfast Symposium
7:00am - 8:15am
New advances of Diabetes Conversations with Best practices around the world
Meeting Room 211
MSD Australia Breakfast Symposium
7:00am - 8:15am
Current and future trials shaping the landscape of diabetes treatment
Meeting Room 212
Novo Nordisk Breakfast Symposium
7:00am - 8:15am
Diabetes and pregnancy – Latest updates
Meeting Room 213
Janssen Breakfast Symposium
7:00am - 8:15am
Meeting Room 219-220
Use of evidence in clinical practice: should we apply treatment guidelines or clinical judgement?
Plenary Lecture
ADEA Jan Baldwin Oration
8:30am - 10:00am
*Recorded Session*
Chair: Tracy Aylen
8:30 AM
Shirley Cornelius
Collaboration - A Pathway for service Delivery in Rural Communities
9 :30 AM
Presentation of next years award
Plenary Hall 2
abs# 87
Concurrent Sessions
ADS Symposium: Type 1 Diabetes Consulting Skills
8:30am - 10:30am
*Recorded Session*
*GP CME Eligible Session*
Meeting Room 219-220
This conference acknowledges the sponsorship of BI & Lilly Alliance
Chair: David McIntyre
Enhancing your consulting skills: Supporting self-management and optimising mental health in people who have Type
1 Diabetes abs# 88
8.30 AM
Jennifer Conn
Introduction
8:40 AM
Jennifer Coburn and Renza Scibilia
Understanding the consumer perspective
9:10 AM
Christel Hendrieckx, Alison Nankervis and Jennifer Conn
Consulting skills for supporting self-management
9:40 AM
Carol Silberberg
Consulting skills for optimising mental health
10:10 AM
Jennifer Conn, Renza Scibilia, Jennifer Coburn, Christel Hendrieckx, Alison Nankervis and Carol
Silberberg
Panel discussion
ADS Basic Symposium: The Endothelium in Glucose Metabolism
8:30am - 10:30am
Meeting Room 212
Chair: Benjamin Lamont
8:30 AM
Lindsay Wu
VEGF and the endothelium in insulin resistance and exercise abs# 89
9:00 AM
Pierre Scotney
Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes abs# 90
9:30 AM
Claire Jessup
Endothelial progenitor cells enhance islet engraftment, influence beta cell function and modulate
islet connexin 36 expression abs# 91
10:00 AM
David Le Couteur
Title not available at time of print abs# 92
ADS Clinical Orals: Treatments
8:30am - 10:30am
Meeting Room 217
Chairs: Michael d'Emden & Stephen Stranks
8:30 AM
John Wentworth
The Effect of Weight Loss on Indigenous Australians with Diabetes: A study of Feasibility,
Acceptability and Compliance for Laparoscopic Adjustable Gastric Banding abs# 93
8:45 AM
Stephen Twigg
New Insulin Glargine 300 U/mL: Glycaemic Control and Hypoglycaemia in Insulin Naïve People with
T2DM (EDITION 3) abs# 94
9:00 AM
William Cook
Dual Add-On Therapy in Poorly Controlled Type 2 Diabetes on Metformin: Randomized, DoubleBlind Trial of Saxagliptin +Dapagliflozin vs. Saxagliptin and Dapagliflozin Alone abs# 95
9:15 AM
David O'Neal
Lixisenatide added to basal insulin reduces glycaemic variability in patients with type 2 diabetes
mellitus abs# 96
9:30 AM
Tania Markovic
Are eggs good for people with type 2 diabetes mellitus? The DIABEGG study abs# 97
9:45 AM
David Hoffman
How effective are GLP-1 agonists in real world practice - a multi centre study from the Australian
S4S- DINGO - Diabetes Informatics Group abs# 98
10:00 AM
Sultan Linjawi
Efficacy and safety of once-daily biphasic insulin aspart 70/30 (BIAsp 30) with sitagliptin and twicedaily BIAsp 30 with or without sitagliptin in patients with type 2 diabetes – the Sit2Mix trial abs# 99
10:15 AM
Ian Caterson
Liraglutide 3.0 mg Reduces the Prevalence of Prediabetes and Delays Onset of Type 2 Diabetes in
Overweight and Obese Adults: Results from SCALE Obesity and Prediabetes, a Randomized, Doubleblind and Placebo-controlled 56-week Trial abs# 100
ADS Basic Orals: Beta Cells in Diabetes
8:30am - 10:30am
Meeting Room 218
Chair: Ross Laybutt & Helen Thomas
8:30 AM
Barton Wicksteed
PKA-mediated potentiation of acute insulin release enhances insulin action and reverses glucose
intolerance abs# 101
8:45 AM
Viviane Delghingaro-Augusto
NODk compared to C57BL/10 Mice are more Prone to Islet Beta-Cell Failure Due to Greater
Susceptibility to Endoplasmic Reticulum Stress abs# 102
9:00 AM
Charmaine Simeonovic
Depletion of beta cell heparan sulfate (HS) in T2D-prone db/db mice results from diminished
heparan sulfate proteoglycan (HSPG) core protein levels abs# 103
9:15 AM
Rebecca Stokes
Islet Transplant Sites for Human and Murine Islets abs# 104
9:30 AM
Wilson Wong
Comparative analysis of Insulin-producing cells in pancreas, gallbladder and the brain abs# 105
9:45 AM
10:00 AM
10:15 AM
Diane Vue
Genetic Deletion of the Endoplasmic Reticulum Gene Herpud1 Results in Impaired Insulin Secretion
abs# 106
Fang-Xu Jiang
Pancreas-specific Deletion of Bmpr1a Impairs Glucose Homeostasis Linked to Overexpression of
Tph1 abs# 107
Gaurang Jhala
Recessive tolerance to proinsulin in early life is sufficient to prevent autoimmunity in NOD mice
abs# 108
ADEA Meeting: Private Practice SIG
10:00am – 11:00am
Meeting Room 211
Morning Tea
10:30am - 11:00am
Trade Exhibition Hall
This conference acknowledges the sponsorship of Roche Diagnostics POC
Plenary Lecture
ADS Plenary Lecture
11:00am - 11:30am
*Recorded Session*
Plenary Hall 2
This conference acknowledges the sponsorship of Eli Lilly Australia
Chair: David James
11:00 AM
Alan Attie
How Can Genetics Help us Understand and Treat Type 2 Diabetes? abs# 109
ADEA Meeting: Clinical Practice Committee
11:00am - 12:30pm
Hospitality Suite 5.201 & 5.202
Concurrent Sessions
ADEA Symposium: Measuring Beyond Glycaemia - The Importance of Other Quality Indicators
11:00am - 1:00pm
*Recorded Session*
*GP CME Eligible Session*
Meeting Room 219-220
This conference acknowledges the sponsorship of Astra Zeneca
Chairs: Liz Obersteller & Trish Roderick
11:00 AM
Sophia Zoungas
Lessons from the Australian National Diabetes Audit (ANDA) abs# 112
11:40 AM
Teresa Pearson
The USA Experience abs# 111
12:20 PM
Trisha Dunning
Measuring beyond glycaemia: the importance of other quality indicators abs# 110
ADEA Orals: Supporting Strategies to Assist Person with T2DM
11:00am - 1:00pm
Meeting Room 211
Chairs: Heather Hart & Ann Bush
11:00 AM
Jo-Anne Manski-Nankervis
Organisational and health professional factors impacting on insulin initiation: An exploratory
qualitative study abs# 113
11:15 AM
Sally Savage
Individualised medicine education for people with type 2 diabetes abs# 114
11:30 AM
Ahmad Wibisono
The lived experience of diabetes educators in educating people with type 2 diabetes who have a fear
of injections abs# 115
11:45 AM
12:00 PM
Michelle Tong
Label reading, is as easy as 1, 2, 3 – The online ‘Healthy Shopping’ abs# 116
Giuliana Murfet
Benefits of GLP-1 Analogue and Insulin Combinations in a Nurse Practitioner Supported Service
abs# 117
ADEA Orals: Management Challenges for Diabetes Health Professionals
11:00am - 1:00pm
Meeting Room 212
Chairs: Michelle Robins & Nicole Duggan
11:00 AM
Angela Simons
Communicating Diabetes to Culturally and Linguistically Diverse Clients abs# 118
11:15 AM
Heather Hart
Driving: Accelerating the Licence Review Process abs# 119
11:30 AM
Marlene Payk
The Nurse Practitioner role in pre admission diabetes management abs# 120
11:45 AM
Denise Bennetts
Decreasing risks of medication errors in patients prescribed Humulin R U-500 abs# 121
12:00 PM
Kirsty Boltong
Evaluation of Education Program Accompanying a New Subcutaneous Insulin Chart abs# 122
Plenary Lectures
ADS Plenary Lecture
11:30am - 12:00pm
*Recorded Session*
Plenary Hall 2
This conference acknowledges the sponsorship of Takeda Australia
Chair: Karin Jandeleit-Dahm
11:30 AM
Kumar Sharma
Metabolomics and Mitochondria in Human Diabetic Nephropathy: New Insights and Pathway for
Therapeutics abs# 123
ADS Kellion Award Lecture
12:00pm - 1:00pm
*Recorded Session*
Chair: Jenny Gunton
12:00 PM
Timothy Davis
The natural history of diabetes: A view from the West
Plenary Hall 2
abs# 124
Lunch
1:00pm - 2:00pm
Trade Exhibition Hall
This conference acknowledges the sponsorship of Abbott Diabetes Care
ADEA Meeting: Credentialling Committee
1:00pm - 2:00pm
Meeting Room 212
NADC Expert Forum
1:15pm - 2:00pm
*Recorded Session*
Chair: Frank Alford
1:15 PM
Hugh Taylor
Eye Care for Diabetes, an Indigenous Perspective
Meeting Room 219-220
abs# 125
ADEA Workshop: How to Write for the ADE
1:30pm - 3:30pm
Meeting Room 218
ADEA Mentoring Session
2:00pm - 2:30pm
*Recorded Session*
Meeting Room 219-220
ADEA Poster Viewing Two
2:00pm - 3:00pm
Please see the poster listing for all presenters.
Trade Exhibition Hall
ADS Clinical Poster Viewing & Discussion
2:00pm - 3:00pm
Please see poster listing for poster presenters and those giving short discussions.
Trade Exhibition Hall
Concurrent Sessions
ADEA Orals: Challenges of Managing Diabetes in the Older Person
2:00pm - 3:00pm
Plenary Hall 2
*Recorded Session*
Chairs: Janelle Babare & Susan McConville
2:00 PM
Trisha Dunning
Implementing the McKellar Guidelines for Managing Older People with Diabetes in Residential and
other Care Settings (The Guidelines): some quality use of medicine issues abs# 126
2:15 PM
Trisha Dunning
Caring for older people with diabetes: do guidelines help health professionals plan individualised
care? abs# 127
2:30 PM
Nicole Duggan
Community-dwelling Older People with Diabetes’ Perspective of Diabetes Self-Care abs# 128
2:45 PM
Julie Loughran
Strategies to Improve Management of Hypoglycaemia in Sub-Acute Care abs# 129
ADEA Orals: Importance of Psychology Health in Person with Diabetes
2:00pm - 3:00pm
Meeting Room 212
Chairs: Patricia Streitberger & Ninnette Kelly
2:00 PM
Sue Wyatt
A Study Examining the Physical, Psychological and Cognitive Effects of Continuous Subcutaneous
Insulin Infusion Therapy (Csii) in Type I Diabetes abs# 130
2:15 PM
Kay Wilhelm
The Importance of Screening for Mild Depression within a Diabetes Service abs# 131
2:30 PM
Lisa Engel
When Being Overweight is the Least of Your Problems abs# 132
2:45 PM
Lisa Robins
Pathways to mental healthcare: online assessment and feedback report abs# 133
Lunchtime Meetings:
ADEA Meeting: Constitution Review Working Group
2:00pm - 3:00pm
Hospitality Suite 5.204
Afternoon Tea
3:00pm - 3:30pm
Trade Exhibition Hall
This conference acknowledges the sponsorship of Servier Laboratories
ADEA Meeting: Oral and Poster Award Moderation
3:00pm - 4:00pm
Hospitality Suite 5.204
ADEA Annual General Meeting
3:30pm - 5:00pm
Plenary Hall 2
Concurrent Sessions
ADS Pincus Taft Young Investigators Award Session
3:30pm - 5:30pm
Meeting Room 219-220
*Recorded Session*
Chairs: Jenny Gunton & Ross Laybutt
3:30 PM
Jay Jha
Global deletion of Nox4 as well as podocyte specific Nox4 deletion attenuates albuminuria in
diabetic nephropathy abs# 134
3:45 PM
Jessie Yang
Novel Mouse Models of Diabetes Susceptibility in the Collaborative Cross Dissect Complex
Pathogenesis of Type 2 Diabetes abs# 135
4:00 PM
Linda Ban
Microparticles are vectors for CD147-mediated hepatocyte injury and stellate cell activity in nonalcoholic steatohepatitis abs# 136
4:15 PM
Elisabeth Malle
The non-canonical NFκB pathway as a novel player in beta cell dysfunction in diabetes abs# 137
4:30 PM
Danielle Borg
Lowering glycation products in experimental autoimmune diabetes reduces islet inflammation
through islet localised effects
abs# 138
4:45 PM
Chrysovalantou Xirouchaki
Skeletal muscle-specific glycogen synthase 1 gene (gys1) deletion in mice results in insulin resistance
associated with reduced GLUT4 levels abs# 139
5:00 PM
Michael Kraakman
Therapeutic blockade of IL-6 trans-signaling increases adipogenesis, prevents adipose tissue
inflammation and does not exacerbate liver steatosis or insulin resistance in obesity abs# 140
5:15 PM
Lewin Small
Reduced glucose uptake in muscle of high fat-fed rats is associated with lower pyruvate
dehydrogenase activity without changes in insulin signalling abs# 141
ADS Clinical Orals: Diabetes in Pregnancy / GDM
3:30pm - 5:30pm
Meeting Room 213
Chairs: Jennifer Conn & Glynis Ross
3:30 PM
Tang Wong
Are the Institute of Medicine targets for pregnancy weight gain appropriate in women with
Gestational diabetes? abs# 142
3:45 PM
Lorraine Pereira
Metformin Treatment of Gestational Diabetes Results in Similar Glycaemic Control and Infant
Outcomes but Less Maternal Weight Gain Than Insulin Treatment abs# 143
4:00 PM
I-Lynn Lee
Maternal and birth outcomes of women with diabetes in pregnancy in the Northern Territory:
PANDORA Study abs# 144
4:15 PM
Nathalie Kizirian
Maternal diet, fetal growth and body composition in women at high risk of gestational diabetes
abs# 145
4:30 PM
Jeff Flack
Gestational Weight Gain in Obese Women with Gestational Diabetes: Maternal and Baby Outcomes
in a Multi-ethnic Cohort in South Western Sydney abs# 146
4:45 PM
Robyn Barnes
Ethnic differences in pregnancy outcomes in women with Gestational Diabetes Mellitus abs# 147
5:00 PM
Robyn Barnes
Ethnic differences in gestational weight gain and pregnancy outcomes in women with Gestational
Diabetes Mellitus abs# 148
5:15 PM
Sally Abell
Gestational diabetes mellitus and adverse pregnancy outcomes: experience from Victoria’s largest
healthcare service abs# 149
ADS Clinical Symposium: Pitfalls in Big Data Analyses
3:30pm - 5:30pm
Meeting Room 217
Chair: Wendy Davis
3:30 PM
Wendy Davis
Hospital Morbidity Coding abs# 150
4:00 PM
Chris Reid
Administrative Data Sets and Clinical Quality Registries – Strengths and Weaknesses abs# 151
4:30 PM
Grant Morahan
Genetics in the “Big Data” Era: Strengths and Limitations abs# 152
5:00 PM
Dianna Magliano
Pitfalls in meta-analyses and data pooling projects abs# 153
ADS Annual General Meeting
5:30pm - 6:30pm
Only ADS Members are able to attend the Annual General Meeting
Meeting Room 219-220
Conference Dinner
7:00pm - 11:30pm
This is a ticketed function.
Melbourne Room
This conference acknowledges the sponsorship of MSD Australia
SCIENTIFIC PROGRAM – Friday 29th August, 2014
Novo Nordisk Changing Diabetes® Fun Run/Walk
6:15am - 9:00am
This conference acknowledges the sponsorship of Novo Nordisk
The start & finish will be outside the front of the Melbourne Convention and Exhibition Centre, South Wharf.
Concurrent Sessions
ADS & ADEA Joint Symposium: Technology 101
9:00am - 11:00am
Plenary Hall 2
*Recorded Session*
*GP CME Eligible Session*
Chair: Brett Fenton
9:00 AM
Natalie Wischer
Using technology and social media in your practice to improve outcomes in diabetes care abs# 154
9:30 AM
Sid Verma
Secure, Paperless and Efficient - Using technology to build, run and manage YOUR practice
abs# 155
10:00 AM
Annette Hicks
“Watson – From Jeopardy to Healthcare” abs# 156
10:30 AM
Alison Lancaster
Diabetes Apps 101 abs# 157
ADS Clinical Symposium: Hypoglycaemia
9:00am - 11:00am
*Recorded Session*
*GP CME Eligible Session*
Meeting Room 219-220
This conference acknowledges the sponsorship of Takeda Australia
Chairs: Peter Colman & N Wah Cheung
9:00 AM
Fergus Cameron
Hypoglycaemia and the developing brain abs# 158
9:30 AM
Tim Jones
Hypoglycemia Update abs# 159
10:00 AM
Sophia Zoungas
Hypoglycaemia: Have we underestimated the problem in patients with Diabetes? abs# 160
10:30 AM
Tony Verberne
Adrenaline and the Glucose Counterregulatory Response: An Orexinergic Connection abs# 161
ADS Basic Orals: Gene Mitochondria & Insulin Resistance
9:00am - 11:00am
Meeting Room 213
Chair: Carsten Schmitz-Peiffer & Tamara Allen
9:00 AM
2013 ADS Skip Martin Early Career Fellowship Awardee
Darren Henstridge
HSP72 prevents peripheral tissue lipotoxicity and preserves insulin sensitivity by increasing oxidative
metabolism in skeletal muscle abs# 162
9:15 AM
Hayley Nicholls
Reducing C16:0 ceramide via ablation of CerS6, but not CerS5, protects against HFD-induced obesity
and WAT inflammation abs# 163
9:30 AM
Brian Drew
Imbalanced PKA-calcineurin signaling impairs mitochondrial health and insulin action in skeletal
muscle deficient in estrogen-receptor alpha (ERα) abs# 164
9:45 AM
Sandra Galic
AMPK control of hypothalamic lipid metabolism: regulation of appetite and body weight abs# 165
10:00 AM
10:15 AM
10:30 AM
10:45 AM
Salvatore Mangiafico
Rapid Identification of Obesity and Type 2 Diabetes Susceptibility Genes Using The ‘Gene Mine’
abs# 166
Brenna Osborne
In vivo overexpression of the mitochondrial deacylase SIRT3 in muscle has no effect on glucose
metabolism and peripheral insulin resistance in the high fat fed rat abs# 167
Ishita Bakshi
Overexpression of Acyl CoA thioesterase7 in the skeletal muscle increases fatty acid oxidation
abs# 168
Hassina Massudi
SIRT1 improves metabolic function in mice
abs# 169
ADS Clinical Orals: Complications
9:00am - 11:00am
Meeting Room 217
Chairs: Mark Cooper & Elif I Ekinci
9:00 AM
Anna Wood
Estimating Glomerular Filtration Rate: the Performance of the CKD-EPI Equation over time in
Patients with Type 2 Diabetes abs# 170
9:15 AM
Michele Clarke
Inverse relationship of urinary protein fragments to albumin excretion rate in Type 2 Diabetes
abs# 171
9:30 AM
Joan Li
Diabetic Foot Complications and Depression: A Cross-Sectional Study in a High Risk Cohort
abs# 172
9:45 AM
Richard Gauci
Anaemia complicating diabetes: The Fremantle Diabetes Study Phase II abs# 173
10:00 AM
Timothy Davis
Improved survival in type 2 diabetic patients hospitalised with an acute coronary syndrome between
1992 and 2007: The Fremantle Diabetes Study Phase I abs# 174
10:15 AM
Natalie Nanayakkara
Age of diagnosis associated with age at first myocardial infarction in type 2 diabetes abs# 175
10:30 AM
Maria Constantino
Why do people with younger onset type 2 diabetes have more retinopathy? abs# 176
10:45 AM
Azni Abdul-Wahab
The use of Serum Fibrotic Markers to predict NAFLD in obese subjects undergoing bariatric surgery
abs# 177
ADS/ADEA/ANZOS Joint Symposium: Nutrition in Diabetes
9:00am - 11:00am
Meeting Room 218
Chair: Nicole Kellow & Melinda Coughlan
9:00 AM
Amanda (Sainsbury) Salis
Intermittent fasting diets for diabetes – safety, effectiveness and potential improvements abs# 178
9:30 AM
Jennie Brand-Miller
The high protein-low GI diet for diabetes abs# 179
10:00 AM
Tim Crowe
Paleo and low-carbohydrate diets for diabetes: today's fads or tomorrow’s advice? abs# 180
10:30 AM
Catherine Itsiopoulos
The Mediterranean Diet: Optimal Solution for Diabetes Management? abs# 181
Morning Tea
11:00am - 11:30am
Trade Exhibition Hall
This conference acknowledges the sponsorship of Diabetes Australia
Concurrent Sessions
ADS Symposium: Exercise in Diabetes
11:30am - 1:30pm
Plenary Hall 2
*Recorded Session*
*GP CME Eligible Session*
Chair: Sean McGee
11:30 AM
Timothy Noakes
Is a high carbohydrate diet essential for all exercisers regardless of their state of insulin resistance?
abs# 182
12:00 PM
Paul Fournier
Strengths and Limitations of Some of the Current Strategies to Prevent Exercise-Mediated
Hypoglycaemia in Individuals with Type 1 Diabetes abs# 183
12:30 PM
David Dunstan
Title not available at time of print abs# 184
1:00 PM
John Hawley
“Exercise-snacking” to improve glucose control abs# 185
ADS Clinical Trials Update
11:30am - 1:00pm
Meeting Room 219-220
*Recorded Session*
*GP CME Eligible Session*
Chair: Sophia Zoungas & Timothy Davis
11:30 AM
Rury Holman
Title not available at time of print abs# 186
12:00 PM
Richard O'Brien
Moving beyond statins: the potential of PCSK9 inhibition for reducing cardiovascular risk abs# 187
12:30 PM
Stephen Twigg
Clinical Trials in the New Insulin Glargine 300 U/mL in Type 2 Diabetes abs# 188
ADS Clinical Orals - Type 1 Diabetes / Hypoglycaemia / Insulin
11:30am - 1:30pm
Meeting Room 217
Chair: Jane Holmes-Walker & Christopher Nolan
11:30 AM
Sybil McAuley
First Evaluation of an Orthogonally Redundant Glucose Sensor in People with Type 1 Diabetes
abs# 189
11:45 AM
Michele Mack
An analysis of clinician contacts in the long term management of insulin pumps compared with an
intensive insulin adjustment programme abs# 190
12:00 PM
Jane Holmes-Walker
Impact of Islet Cell Transplantation (ICT) on long-term diabetes complications two years post
transplant abs# 191
12:15 PM
Spiros Fourlanos
Profiling organ-specific autoimmunity in latent autoimmune diabetes in adults abs# 192
12:30 PM
Daniel Fineberg
Glycaemic Variability is Associated with Adverse Psychological Well-being in Adults with Type 1
Diabetes abs# 193
12:45 PM
Richard Burnet
Response of the Physiological Tremor and Catacholamines to Induced Hypoglycaemia in Type 1
Diabetes and Non-diabetic Controls abs# 194
1:00 PM
Rebecca Goldstein
Incidence and determinants of minor and major hypoglycaemia in type 2 diabetes abs# 195
1:15 PM
Gregory Fulcher
Intensification from basal insulin in type 2 diabetes? Retrospective audit of clinical practice from four
Australian centres abs# 196
ADS Basic Symposium: Mediators of Inflammation in Diabetes and Metabolism
11:30am - 1:30pm
Meeting Room 218
Chair: Mark Febbraio
11:30 AM
Andrew Murphy
Fattening and Sweetening of Haematopoietic Stem Cells: Effects on Monocyte Production
abs# 197
12:00 PM
Laurence Macia
Dietary fibre induces gut homeostasis through metabolite-sensing GPCRs and regulation of the
inflammasome pathway abs# 198
12:30 PM
Graeme Lancaster
Re-examining the role of toll-like receptor 4 (TLR4) as a sensor of free fatty acids abs# 199
1:00 PM
Bala Krishnamurthy
Mechanism of Tolerance to Proinsulin in NOD mice abs# 200
ADEA Awards Presentation
11:30am - 12:00pm
Meeting Room 211
ADEA Credentialling Session & CPD Workshop
12:00pm - 1:30pm
Meeting Room 211
Lunch
1:00pm - 2:00pm
Lunch boxes will be provided.
Main Foyer
Medical Education and Scientific Advisory Council Meeting
1:00pm - 3:00pm
Hospitality Suite 5.201 & 5.202
John R. Turtle Diabetes Clinical Skills Training Course for Advanced Trainees in Endocrinology
1:00pm - 5:30pm, Meeting Room 212-213
ADS acknowledges the support of Servier Laboratories & Eli Lilly
ADS GP Afternoon Workshop
1:30pm - 4:30pm
*Recorded Session*
*GP CME Eligible Session*
1:30 PM
Jennifer Conn
Consulting skills for diabetes
2:00 PM
Jonathan Shaw
HbA1c: new numbers, new uses
2:30 PM
Afternoon Tea
3:00 PM
Jenny Gunton
SGLT2 inhibitors: Clinical use in type 2
3:30 PM
Roy Rasalam
Diabetic foot disease management
4:00 PM
Dianna Fornasier
What happens when you refer a patient to a CDE?
Meeting Room 211
Consumer Outreach
1:30pm - 5:00pm
1:30 PM
2:30 PM
3:15 PM
4:00 PM
Meeting Room 218
Lunch
Debate - "Is the target realistic?"
Moderator: Trisha Dunning
Health Professionals: John Wentworth & Adam Roberts
Consumers: Monique Hanley & Renza Scibilia
How to minimise the stress of exercising with diabetes
Monique Hanley
Afternoon Tea and Networking
ADEA Meeting: 2015 Program Organising Committee
2:00pm - 3:00pm
Hospitality Suite 5.204

Download Report